FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3162252981> ?p ?o ?g. }

• W3162252981 endingPage "58" @default.
• W3162252981 startingPage "49" @default.
• W3162252981 abstract "Preclinical data suggest that the ageing-induced miR-34a regulates vascular senescence. Herein we sought to assess whether the miR-34 family members miR-34a, miR-34b and miR-34c are involved in human arterial disease.Expression levels of miR-34a/b/c were quantified by TaqMan assay in peripheral blood mononuclear cells (PBMCs) derived from a consecutive cohort of 221 subjects who underwent cardiovascular risk assessment and thorough vascular examination for aortic stiffness and extent of arterial atherosclerosis.High miR-34a was independently associated with the presence of CAD [OR (95%C.I.): 3.87 (1.56-9.56); p = 0.003] and high miR-34c with the number of diseased arterial beds [OR (95%C.I.): 1.88 (1.034-3.41); p = 0.038], while concurrent high expression of miR-34-a/c or all three miR-34a/b/c was associated with aortic stiffening (miR-34a/c: p = 0.022; miR-34a/b/c: p = 0.041) and with the extent of atherosclerosis [OR (95%C.I.) for number of coronary arteries [miR-34a/c: 3.29 (1.085-9.95); miR-34a/b/c: 6.06 (1.74-21.2)] and number of diseased arterial beds [miR-34a/c: 3.51 (1.45-8.52); miR-34a/b/c: 2.89 (1.05-7.92)] after controlling for possible confounders (p < 0.05 for all). Mechanistically, the increased levels of miR-34a or miR-34c were inversely associated with expression of SIRT1 or JAG1, NOTCH2, CTNNB1 and ATF1, respectively. The association of miR-34a/c or miR-34a/b/c with CAD was mainly mediated through SIRT1 and to a lesser extent through JAG1 as revealed by generalized structural equation modeling. Leukocyte-specific ablation of miR-34a/b/c ameliorates atherosclerotic plaque development and increases Sirt1 and Jag1 expression in an atherosclerosis mouse model confirming the human findings.The present study reveals the clinical significance of the additive role of miR-34a/b/c in vascular ageing and atherosclerotic vascular disease." @default.
• W3162252981 created "2021-05-24" @default.
• W3162252981 creator A5002993341 @default.
• W3162252981 creator A5004560260 @default.
• W3162252981 creator A5016467806 @default.
• W3162252981 creator A5018105714 @default.
• W3162252981 creator A5020748819 @default.
• W3162252981 creator A5025706940 @default.
• W3162252981 creator A5027172318 @default.
• W3162252981 creator A5034130684 @default.
• W3162252981 creator A5035176276 @default.
• W3162252981 creator A5036590856 @default.
• W3162252981 creator A5037234422 @default.
• W3162252981 creator A5037425426 @default.
• W3162252981 creator A5047030683 @default.
• W3162252981 creator A5058528410 @default.
• W3162252981 creator A5061907666 @default.
• W3162252981 creator A5066082619 @default.
• W3162252981 creator A5067110082 @default.
• W3162252981 creator A5070802022 @default.
• W3162252981 creator A5072821844 @default.
• W3162252981 creator A5081342175 @default.
• W3162252981 date "2021-06-01" @default.
• W3162252981 modified "2023-10-01" @default.
• W3162252981 title "Additive contribution of microRNA-34a/b/c to human arterial ageing and atherosclerosis" @default.
• W3162252981 cites W144423133 @default.
• W3162252981 cites W1936833235 @default.
• W3162252981 cites W1963952972 @default.
• W3162252981 cites W1974532808 @default.
• W3162252981 cites W2001382962 @default.
• W3162252981 cites W2004067791 @default.
• W3162252981 cites W2006173503 @default.
• W3162252981 cites W2018771531 @default.
• W3162252981 cites W2019106516 @default.
• W3162252981 cites W2030093783 @default.
• W3162252981 cites W2037668591 @default.
• W3162252981 cites W2038970025 @default.
• W3162252981 cites W2055438942 @default.
• W3162252981 cites W2055864845 @default.
• W3162252981 cites W2061077538 @default.
• W3162252981 cites W2066670499 @default.
• W3162252981 cites W2070135829 @default.
• W3162252981 cites W2070765029 @default.
• W3162252981 cites W2077236610 @default.
• W3162252981 cites W2077475358 @default.
• W3162252981 cites W2077612517 @default.
• W3162252981 cites W2089146881 @default.
• W3162252981 cites W2090374150 @default.
• W3162252981 cites W2104268053 @default.
• W3162252981 cites W2105397247 @default.
• W3162252981 cites W2112943642 @default.
• W3162252981 cites W2130253814 @default.
• W3162252981 cites W2131985274 @default.
• W3162252981 cites W2133416234 @default.
• W3162252981 cites W2138413381 @default.
• W3162252981 cites W2138477343 @default.
• W3162252981 cites W2149908223 @default.
• W3162252981 cites W2155794059 @default.
• W3162252981 cites W2158618709 @default.
• W3162252981 cites W2168513601 @default.
• W3162252981 cites W2171546997 @default.
• W3162252981 cites W2176735297 @default.
• W3162252981 cites W2400928288 @default.
• W3162252981 cites W2512481987 @default.
• W3162252981 cites W2520933444 @default.
• W3162252981 cites W2588025094 @default.
• W3162252981 cites W2603942390 @default.
• W3162252981 cites W2613556062 @default.
• W3162252981 cites W2624994355 @default.
• W3162252981 cites W2625306360 @default.
• W3162252981 cites W2767546566 @default.
• W3162252981 cites W2803089807 @default.
• W3162252981 cites W2883930296 @default.
• W3162252981 cites W2903261820 @default.
• W3162252981 cites W2972234201 @default.
• W3162252981 cites W2972352204 @default.
• W3162252981 cites W2995721821 @default.
• W3162252981 cites W3003299879 @default.
• W3162252981 cites W3043760418 @default.
• W3162252981 doi "https://doi.org/10.1016/j.atherosclerosis.2021.05.005" @default.
• W3162252981 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34038763" @default.
• W3162252981 hasPublicationYear "2021" @default.
• W3162252981 type Work @default.
• W3162252981 sameAs 3162252981 @default.
• W3162252981 citedByCount "21" @default.
• W3162252981 countsByYear W31622529812021 @default.
• W3162252981 countsByYear W31622529812022 @default.
• W3162252981 countsByYear W31622529812023 @default.
• W3162252981 crossrefType "journal-article" @default.
• W3162252981 hasAuthorship W3162252981A5002993341 @default.
• W3162252981 hasAuthorship W3162252981A5004560260 @default.
• W3162252981 hasAuthorship W3162252981A5016467806 @default.
• W3162252981 hasAuthorship W3162252981A5018105714 @default.
• W3162252981 hasAuthorship W3162252981A5020748819 @default.
• W3162252981 hasAuthorship W3162252981A5025706940 @default.
• W3162252981 hasAuthorship W3162252981A5027172318 @default.
• W3162252981 hasAuthorship W3162252981A5034130684 @default.
• W3162252981 hasAuthorship W3162252981A5035176276 @default.

• next